{"title":"综述文章:建立亚洲老年酸相关疾病管理的算法","authors":"F. K. L. CHAN, Y. KINOSHITA","doi":"10.1111/j.1746-6342.2007.00078.x","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>The special needs of the elderly must be considered in the treatment of acid-related disorders in older patients. Workshop participants discussed the Genval workshop report algorithm as a step toward building a consensus on the management of elderly patients in Asia.</p>\n <p>The consensus reached is summarized as follows:</p>\n <p>(i) old age alone is an indication for endoscopic investigation of reflux symptoms;</p>\n <p>(ii) elderly patients should undergo endoscopy when they present with acid reflux symptoms;</p>\n <p>(iii) a biopsy-based test for <i>Helicobacter pylori</i> should be performed if endoscopy is done, and eradication of <i>H. pylori</i> is warranted as it will reduce the risk of peptic ulcers and may retard the progression of early precancerous gastric lesions;</p>\n <p>(iv) it is not recommended to routinely take additional biopsies for histology in patients with <i>H. pylori</i> infection in the absence of any macroscopic suspicious lesions;</p>\n <p>(v) patients with reflux disease LA grade B or below should be started on a standard-dose proton pump inhibitor for 4–8 weeks, and then followed by step-down to on-demand therapy;</p>\n <p>(vi) patients with LA grade C or above reflux oesophagitis should be initially given standard-dose proton pump inhibitor therapy for at least 8 weeks and then continue with maintenance proton pump inhibitor therapy.</p>\n </div>","PeriodicalId":50822,"journal":{"name":"Alimentary Pharmacology & Therapeutics Symposium Series","volume":"3 2","pages":"27-30"},"PeriodicalIF":0.0000,"publicationDate":"2007-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1746-6342.2007.00078.x","citationCount":"0","resultStr":"{\"title\":\"Review article: building an algorithm for the management of geriatric acid-related disorders in Asia\",\"authors\":\"F. K. L. CHAN, Y. KINOSHITA\",\"doi\":\"10.1111/j.1746-6342.2007.00078.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p>The special needs of the elderly must be considered in the treatment of acid-related disorders in older patients. Workshop participants discussed the Genval workshop report algorithm as a step toward building a consensus on the management of elderly patients in Asia.</p>\\n <p>The consensus reached is summarized as follows:</p>\\n <p>(i) old age alone is an indication for endoscopic investigation of reflux symptoms;</p>\\n <p>(ii) elderly patients should undergo endoscopy when they present with acid reflux symptoms;</p>\\n <p>(iii) a biopsy-based test for <i>Helicobacter pylori</i> should be performed if endoscopy is done, and eradication of <i>H. pylori</i> is warranted as it will reduce the risk of peptic ulcers and may retard the progression of early precancerous gastric lesions;</p>\\n <p>(iv) it is not recommended to routinely take additional biopsies for histology in patients with <i>H. pylori</i> infection in the absence of any macroscopic suspicious lesions;</p>\\n <p>(v) patients with reflux disease LA grade B or below should be started on a standard-dose proton pump inhibitor for 4–8 weeks, and then followed by step-down to on-demand therapy;</p>\\n <p>(vi) patients with LA grade C or above reflux oesophagitis should be initially given standard-dose proton pump inhibitor therapy for at least 8 weeks and then continue with maintenance proton pump inhibitor therapy.</p>\\n </div>\",\"PeriodicalId\":50822,\"journal\":{\"name\":\"Alimentary Pharmacology & Therapeutics Symposium Series\",\"volume\":\"3 2\",\"pages\":\"27-30\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1746-6342.2007.00078.x\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alimentary Pharmacology & Therapeutics Symposium Series\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/j.1746-6342.2007.00078.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics Symposium Series","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1746-6342.2007.00078.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在治疗老年患者的酸相关疾病时,必须考虑老年人的特殊需要。研讨会参与者讨论了Genval研讨会报告算法,作为在亚洲建立老年患者管理共识的一步。达成的共识总结如下:(i)仅老年是内镜检查反流症状的指征;(ii)老年患者出现胃酸反流症状时应接受内窥镜检查;(iii)如果进行了内窥镜检查,则应进行基于活检的幽门螺杆菌检查,根除幽门螺杆菌是必要的,因为它将降低消化性溃疡的风险,并可能延缓早期癌前胃病变的进展;(iv)不建议幽门螺杆菌感染患者在没有任何肉眼可疑病变的情况下常规进行额外的组织学活检;(v) LA B级或以下反流疾病患者应开始使用标准剂量质子泵抑制剂4-8周,然后逐步降至按需治疗;(vi) LA C级或以上反流性食管炎患者最初应给予标准剂量质子泵抑制剂治疗至少8周,然后继续维持质子泵抑制剂治疗。
Review article: building an algorithm for the management of geriatric acid-related disorders in Asia
The special needs of the elderly must be considered in the treatment of acid-related disorders in older patients. Workshop participants discussed the Genval workshop report algorithm as a step toward building a consensus on the management of elderly patients in Asia.
The consensus reached is summarized as follows:
(i) old age alone is an indication for endoscopic investigation of reflux symptoms;
(ii) elderly patients should undergo endoscopy when they present with acid reflux symptoms;
(iii) a biopsy-based test for Helicobacter pylori should be performed if endoscopy is done, and eradication of H. pylori is warranted as it will reduce the risk of peptic ulcers and may retard the progression of early precancerous gastric lesions;
(iv) it is not recommended to routinely take additional biopsies for histology in patients with H. pylori infection in the absence of any macroscopic suspicious lesions;
(v) patients with reflux disease LA grade B or below should be started on a standard-dose proton pump inhibitor for 4–8 weeks, and then followed by step-down to on-demand therapy;
(vi) patients with LA grade C or above reflux oesophagitis should be initially given standard-dose proton pump inhibitor therapy for at least 8 weeks and then continue with maintenance proton pump inhibitor therapy.